An Evaluation Of Single And Dual Long-Acting Bronchodilator Therapy As Effective Interventions In Maintenance Therapy-Naïve Patients With COPD

Dave Singh1 Medicines Evaluation Unit, University of Manchester, Manchester University NHS Foundation Trust, Manchester, UKCorrespondence[email protected]

Anthony D D’Urzo2 Department of Family and Community Medicine, University of Toronto, Toronto, ON, Canada

James F Donohue3 Division of Pulmonary Diseases and Critical Care Medicine, University of North Carolina Pulmonary Critical Medicine, Chapel Hill, NC, USA

https://orcid.org/0000-0002-4439-6866

Edward M Kerwin4 Clinical Research Institute, Medford, OR, USA

https://orcid.org/0000-0002-1697-9036

Eduard Molins5 BioPharmaceuticals R&D, AstraZeneca, Barcelona, Spain

Ferran Chuecos5 BioPharmaceuticals R&D, AstraZeneca, Barcelona, Spain

Anna Ribera5 BioPharmaceuticals R&D, AstraZeneca, Barcelona, Spain

Diana Jarreta5 BioPharmaceuticals R&D, AstraZeneca, Barcelona, Spain

show all

An Evaluation Of Single And Dual Long-Acting Bronchodilator Therapy As Effective Interventions In Maintenance Therapy-Naïve Patients With COPD

Information for

Open access

Opportunities

Help and information

Your download is now in progress and you may close this window

Login or register to access this feature

An Evaluation Of Single And Dual Long-Acting Bronchodilator Therapy As Effective Interventions In Maintenance Therapy-Naïve Patients With COPD

Reprints and Permissions

Related research

To cite this article:

Download citation

Information for

Open access

Opportunities

Help and information

Keep up to date